Search results for " sor"

showing 10 items of 408 documents

Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials

2019

Aim: To benchmark overall survival (OS) and time to radiological progression (TTP) of patients enrolled in randomized controlled trials (RCTs) assessing sorafenib in advanced hepatocellular carcinoma using individual participant survival data, and to meta-analyze prognostic factors for OS and TTP. Methods: RCTs were identified through literature search until December 2018. Individual participant survival was reconstructed with an algorithm from published Kaplan–Meier curves. Results: Ten RCTs were included. Median OS was 10.0 months (95% CI: 9.6–10.5), and median TTP was 4.1 months (95% CI: 3.8–4.3). Multivariable analyses showed HCV positivity, absence of macrovascular invasion and extra-…

SorafenibOncologyCancer Researchmedicine.medical_specialtyCarcinoma HepatocellularPhase iii trialsAntineoplastic AgentsDiseasesurvivaltime to progressionSystemic therapysystemic therapylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemeta-regressionmedicineHumansClinical TrialsMeta-regressionbusiness.industryCarcinomaLiver NeoplasmsHepatocellularhepatocellular carcinomaGeneral MedicineSorafenibmedicine.diseasePhase III as TopicSurvival RateTreatment Outcomehepatocellular carcinoma; meta-regression; sorafenib; survival; systemic therapy; time to progression; Antineoplastic Agents; Carcinoma Hepatocellular; Clinical Trials Phase III as Topic; Humans; Liver Neoplasms; Sorafenib; Survival Rate; Treatment OutcomeClinical Trials Phase III as TopicOncology030220 oncology & carcinogenesisHepatocellular carcinomaMeta-analysissorafenib030211 gastroenterology & hepatologybusinessmedicine.drug
researchProduct

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?

2015

According to the guidelines of the European Association for the Study of the Liver (EASL), patients affected from hepatocellular carcinoma (HCC) can be classified according to the Barcelona Clinic Liver Cancer (BCLC) staging system. This classification system divides HCC patients in five stages (0, A, B, C and D) on the basis of a number of prognostic and treatment- related variables such as tumor status and liver function. A specific treat ment approach is then proposed for each of the above-mentioned stages. Transarterial chemoembolization (TACE) is recommended as first-line therapy in the treatment of patients with intermediate-stage (BCLC-B class) HCC [1]. The efficacy of this procedure…

SorafenibOncologyNiacinamideCancer Researchmedicine.medical_specialtyCarcinoma HepatocellularCombination therapyHCC; TACE; combination therapy; intermediate stage; sorafenibAntineoplastic Agentscombination therapyInternal medicineMedicineHumansStage (cooking)Chemoembolization TherapeuticHCCProtein Kinase InhibitorsTACEintermediate stagePerformance statusbusiness.industryPhenylurea CompoundsLiver NeoplasmsGeneral Medicinemedicine.diseaseCombined Modality Therapydigestive system diseasesPortal vein thrombosisSurgeryOncologyHepatocellular carcinomasorafenibLiver functionbusinessLiver cancermedicine.drug
researchProduct

Yin Yang 1 and raf-1 Kinase Inhibitory Protein Status in Hepatocellular carcinoma: Future Perspectives

2010

We focus on to the role of the transcription factors NF-κB and Yin Yang 1 (YY1) and of Raf-1 kinase inhibitory protein (RKIP) in hepatocellular carcinoma (HCC). YY1, whose expression is enhanced by NF-κB, favors tumorigenesis. RKIP inhibits the oncogenic activities of MAPK and NF-κB pathways and promotes drug-induced apoptosis. Mutual influences between YY1 and RKIP may exist and there is separate evidence that relevant increases in YY1 and reductions in RKIP occur in HCC. In a recent study on clinical HCC, we found that, indeed, the ratio of YY1 to RKIP mRNA and protein expression is very frequently profoundly inverted in tumors compared with adjacent tissues. Hyperactivation of YY1 in tum…

SorafenibSettore MED/12 - GastroenterologiaHepatocellular carcinoma Yin Yang 1 RKIP YY1AP NF-kB Sorafenibbusiness.industryInhibitory postsynaptic potentialmedicine.diseaseBiochemistryYIN-YANG-1Hepatocellular carcinomaRaf 1 kinaseSettore BIO/14 - FarmacologiaGeneticsmedicineCancer researchMolecular MedicinebusinessBiotechnologymedicine.drugForum on Immunopathological Diseases and Therapeutics
researchProduct

Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers

2015

Giorgio Lorenzo Colombo,1 Calogero Cammà,2 Adolfo Francesco Attili,3 Roberto Ganga,4 Giovanni Battista Gaeta,5 Giuseppina Brancaccio,5 Jean Marie Franzini,6 Marco Volpe,6 Giuseppe Turchetti7 1Department of Drug Sciences, University of Pavia, Pavia, Italy; 2Section of Gastroenterology, Di.Bi.M.I.S., University of Palermo, Palermo, Italy; 3Department of Clinical Medicine, University of Rome (La Sapienza) Rome, Italy; 4Clinical Medicine Division, Ospedale Brotzu, Cagliari, Italy; 5Viral Hepatitis Unit, Second University, Naples, Italy; 6Business Integration Partners S.p.A., Milan, Italy; 7Scuola Superiore Sant’Anna, Pisa, Italy Background: Hepatocellular carcinoma (HCC) is…

Sorafenibmedicine.medical_specialtyTherapeutics and Clinical Risk ManagementTare weightTransarterial embolizationToxicology and Pharmaceutics (all)DiseaseDisease costDrugs costInternal medicinedisease costsHealth caremedicineDisease costs; Drugs cost; Sorafenib; Transarterial embolization; Medicine (all); Safety Research; Pharmacology Toxicology and Pharmaceutics (all); Chemical Health and Safety; Pharmacology (medical)Pharmacology (medical)General Pharmacology Toxicology and PharmaceuticsStage (cooking)Original ResearchPharmacologyChemical Health and Safetybusiness.industryDisease costs; drugs cost; sorafenib; transarterial embolizationMortality rateMedicine (all)General MedicineSorafenibmedicine.diseasedigestive system diseasesdisease costs drugs cost transarterial embolization sorafenibHepatocellular carcinomaPharmacology Toxicology and Pharmaceutics (all)businessLiver cancerSafety Researchmedicine.drug
researchProduct

Colegio de Sordo-mudos y de Ciegos de Valencia dirigido por las Religiosas Terceras de San Francisco de Asís : detalles acerca de su fundación, de su…

Sords EducacióColegio de Sordo-mudos y ciegos (Valencia)
researchProduct

Design d'un iprodione-MIP (molecularly imprinted polymer) : application à la pré-concentration des fongicides dans le vin

2014

The aim of this study was the synthesis of a MIP (molecularly imprinted polymer) specific for a fungicide that is found in the majority of the french wine: iprodione. The challenge for extracting iprodione from wine medium was that the hydoralcoholic solution is a dipolar solvent, whereas the interaction between the MIP and iprodione is based on dipolar interactions. The first extraction study of iprodione was made on a MIP synthesized by bulk polymerization using methacrylamide and ethylene glycol dimethacrylate (EGDMA). The MIP was found to be more efficient than the NIP (non-imprinted polymer) in hydroalcoholic solutions which demonstrates that the molecular imprinting was successful. Th…

Sorption isotherms[CHIM.GENI] Chemical Sciences/Chemical engineeringIprodioneWineIsothermes d’adsorptionAbsorption de l’eauExperimental designMISPEMIP[CHIM.GENI]Chemical Sciences/Chemical engineeringWater sorptionVinPesticides[ CHIM.GENI ] Chemical Sciences/Chemical engineeringPlan d’experiences
researchProduct

Sorbus busambarensis (Rosaceae), a new endemic species of Sicily

2012

Abstract In this study, Sorbus busambarensis, a new species from Rocca Busambra (Palermo, NW Sicily) has been described and named. On the basis of the critical features of its flowers, fruits and leaves, it is noted to be a member of S. sect. Aria and is related to the other taxa that form the polymorphic group of S. aria, which in Sicily is represented by S. aria s. str., S. graeca and S. umbellata.

SpiraeoideaeSorbusTaxonbiologySpiraeoideae Sorbus aria group Italian flora Sicilian endemics taxonomy.Settore BIO/02 - Botanica SistematicaRosaceaeBotanyTaxonomy (biology)Plant Sciencebiology.organism_classificationEndemismEcology Evolution Behavior and SystematicsPlant Biosystems - An International Journal Dealing with all Aspects of Plant Biology
researchProduct

Pyrrolomycins as antimicrobial agents. Microwave-assisted organic synthesis and insights into their antimicrobial mechanism of action

2019

Abstract New compounds able to counteract staphylococcal biofilm formation are needed. In this study we investigate the mechanism of action of pyrrolomycins, whose potential as antimicrobial agents has been demonstrated. We performed a new efficient and easy method to use microwave organic synthesis suitable for obtaining pyrrolomycins in good yields and in suitable amount for their in vitro in-depth investigation. We evaluate the inhibitory activity towards Sortase A (SrtA), a transpeptidase responsible for covalent anchoring in Gram-positive peptidoglycan of many surface proteins involved in adhesion and in biofilm formation. All compounds show a good inhibitory activity toward SrtA, havi…

Staphylococcus aureusClinical BiochemistryPharmaceutical ScienceMicrobial Sensitivity Testsmedicine.disease_causeSettore BIO/19 - Microbiologia Generale01 natural sciencesBiochemistrychemistry.chemical_compoundBacterial ProteinsDrug DiscoverymedicinePyrrolesEnzyme InhibitorsMicrowavesMolecular BiologyEnzyme Assays010405 organic chemistryChemistryOrganic ChemistryBiofilmN-Acetylmuramoyl-L-alanine AmidaseAntimicrobialAminoacyltransferasesAntimicrobial resistance Pyrrolomycins Sortase A Staphylococcus aureus In-silico docking studies MAOS Pharmacokinetics studies Murein hydrolase activitySettore CHIM/08 - Chimica Farmaceutica0104 chemical sciencesAnti-Bacterial AgentsMolecular Docking Simulation010404 medicinal & biomolecular chemistryCysteine EndopeptidasesBiochemistryMechanism of actionDocking (molecular)Staphylococcus aureusSettore CHIM/03 - Chimica Generale E InorganicaSortase ABiofilmsPseudomonas aeruginosaMolecular MedicineOrganic synthesisPeptidoglycanmedicine.symptom
researchProduct

Self-assembly of metallosupramolecular rhombi from chiral concave 9,9'-spirobifluorene-derived bis(pyridine) ligands.

2014

Two new 9,9’-spirobifluorene-based bis(4-pyridines) were synthesised in enantiopure and one also in racemic form. These ligands act as concave templates and form metallosupramolecular [(dppp)2M2L2] rhombi with cis-protected [(dppp)Pd]2+ and [(dppp)Pt]2+ ions. The self-assembly process of the racemic ligand preferably occurs in a narcissistic self-recognising manner. Hence, a mixture of all three possible stereoisomers [(dppp)2M2{(R)-L}2](OTf)4, [(dppp)2M2{(S)-L}2](OTf)4, and [(dppp)2M2{(R)-L}{(S)-L}](OTf)4 was obtained in an approximate 1.5:1.5:1 ratio which corresponds to an amplification of the homochiral assemblies by a factor of approximately three as evidenced by NMR spectroscopy and m…

Stereochemistryconcave templatesSupramolecular chemistrymetal complexesFull Research Paperself-sortingsupramolecular chemistrylcsh:QD241-441lcsh:Organic chemistrysupramolekulaarinen kemialcsh:Scienceta1169LigandChemistryOrganic ChemistryNuclear magnetic resonance spectroscopyself-assemblyPyridine ligandCrystallographyChemistrySelf sortingEnantiopure drug99’-spirobifluorenelcsh:QSelf-assembly9’-spirobifluoreneSingle crystalBeilstein journal of organic chemistry
researchProduct

Dzintra 45 gados:1924-1969

1969

Studenti Latvijas UniversitātēStudentu organizācijasStudent corporationsHistory of the University of LatviaDzintra (studentu korporācija):SOCIAL SCIENCES::Social sciences::Education [Research Subject Categories]Latvijas Universitātes vēstureLatvian Academic sorority Dzintra
researchProduct